High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor

被引:57
作者
Moy, FJ
Chanda, PK
Chen, JM
Cosmi, S
Edris, W
Levin, JI
Powers, R
机构
[1] Wyeth Ayerst Res, Dept Biol Chem, Cambridge, MA 02140 USA
[2] Wyeth Ayerst Res, Dept Core Biotechnol, Princeton, NJ 08543 USA
[3] Wyeth Ayerst Res, Dept Chem Sci, Pearl River, NY 10965 USA
关键词
NMR; solution structure; matrix metalloproteinase; hydroxamic acid; human collagenase-3;
D O I
10.1006/jmbi.2000.4082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a sulfonamide derivative of a hydroxamic acid compound (WAY-151693) has been determined by multidimensional heteronuclear NMR. A total of 30 structures were calculated for residues 7-164 by means of hybrid distance geometry-simulated annealing using a total of 3280 experimental NMR restraints. The atomic rms distribution about the mean coordinate positions for the 30 structures is 0.43(+/-0.56) Angstrom for the backbone atoms, 0.80(+/-0.09) Angstrom for all atoms, and 0.47(+/-0.04) A for all atoms excluding disordered side-chains. The overall structure of MMP-13 is composed of a beta-sheet consisting of five beta-strands in a mixed parallel and anti-parallel arrangement and three alpha-helices where its overall fold is consistent with previously solved MMP structures. A comparison of the NMR structure of MMP-13 with the published 1.6 Angstrom resolution X-ray structure indicates that the major differences between the structures is associated with loop dynamics and crystal-packing interactions. The side-chains of some active-site residues for the NMR and X-ray structures of MMP-13 adopt distinct conformations. This is attributed to the presence of unique inhibitors in the two structures that encounter distinct interactions with MMP-13. The major structural difference observed between the MMP-13 and MMP-1 NMR structures is the relative size and shape of the S1' pocket where this pocket is significantly longer for MMP-13, nearly reaching the surface of the protein. Additionally, MMP-1 and MMP-13 exhibit different dynamic properties for the active-site loop and the structural Zn-binding region. The inhibitor WAY-151693 is well defined in the MMP-13 active-site based on a total. of 52 distance restraints. The binding motif of WAY-151693 in the MMP-13 complex is consistent with our previously reported MMP-1:CGS27023A NMR structure and is similar to the MMP-13: RS-130830 X-ray structure. (C) 2000 Academic Press.
引用
收藏
页码:671 / 689
页数:19
相关论文
共 94 条
  • [1] AN ALTERNATIVE 3D-NMR TECHNIQUE FOR CORRELATING BACKBONE N-15 WITH SIDE-CHAIN H-BETA-RESONANCES IN LARGER PROTEINS
    ARCHER, SJ
    IKURA, M
    TORCHIA, DA
    BAX, A
    [J]. JOURNAL OF MAGNETIC RESONANCE, 1991, 95 (03): : 636 - 641
  • [2] Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors
    Balbín, M
    Pendás, AM
    Uría, JA
    Jiménez, MG
    Freije, JP
    López-Otín, C
    [J]. APMIS, 1999, 107 (01) : 45 - 53
  • [3] MEASUREMENT OF LONG-RANGE C-13-C-13 J COUPLINGS IN A 20-KDA PROTEIN-PEPTIDE COMPLEX
    BAX, A
    MAX, D
    ZAX, D
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (17) : 6923 - 6925
  • [4] OPTIMIZED RECORDING OF HETERONUCLEAR MULTIDIMENSIONAL NMR-SPECTRA USING PULSED FIELD GRADIENTS
    BAX, A
    POCHAPSKY, SS
    [J]. JOURNAL OF MAGNETIC RESONANCE, 1992, 99 (03): : 638 - 643
  • [5] STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME
    BECKER, JW
    MARCY, AI
    ROKOSZ, LL
    AXEL, MG
    BURBAUM, JJ
    FITZGERALD, PMD
    CAMERON, PM
    ESSER, CK
    HAGMANN, WK
    HERMES, JD
    SPRINGER, JP
    [J]. PROTEIN SCIENCE, 1995, 4 (10) : 1966 - 1976
  • [6] 1.8-angstrom crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate prime-side inhibitor with a distinct selectivity profile
    Betz, M
    Huxley, P
    Davies, SJ
    Mushtaq, Y
    Pieper, M
    Tschesche, H
    Bode, W
    GomisRuth, FX
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (01): : 356 - 363
  • [7] MATRIX METALLOPROTEINASES - A REVIEW
    BIRKEDALHANSEN, H
    MOORE, WGI
    BODDEN, MK
    WINDSOR, LJ
    BIRKEDALHANSEN, B
    DECARLO, A
    ENGLER, JA
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) : 197 - 250
  • [8] THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY
    BODE, W
    REINEMER, P
    HUBER, R
    KLEINE, T
    SCHNIERER, S
    TSCHESCHE, H
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1263 - 1269
  • [9] STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
    BORKAKOTI, N
    WINKLER, FK
    WILLIAMS, DH
    DARCY, A
    BROADHURST, MJ
    BROWN, PA
    JOHNSON, WH
    MURRAY, EJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (02): : 106 - 110
  • [10] Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding
    Botos, I
    Scapozza, L
    Zhang, DC
    Liotta, LA
    Meyer, EF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2749 - 2754